Vaccines (Jan 2023)

Central and Effector Memory Human CD4<sup>+</sup> and CD8<sup>+</sup> T Cells during Cutaneous Leishmaniasis and after In Vitro Stimulation with <i>Leishmania (Viannia) braziliensis</i> Epitopes

  • Beatriz Coutinho de Oliveira,
  • Ailton Alvaro da Silva,
  • Marton Kaique de Andrade Cavalcante,
  • Maria Edileuza Felinto de Brito,
  • Maria Carolina Accioly Brelaz de Castro,
  • Vanessa Lucília Silveira de Medeiros,
  • Rafael de Freitas e Silva,
  • Valéria Rêgo Alves Pereira

DOI
https://doi.org/10.3390/vaccines11010158
Journal volume & issue
Vol. 11, no. 1
p. 158

Abstract

Read online

Cutaneous Leishmaniasis (CL) is a Neglected Tropical Disease characterized by skin ulcers caused by Leishmania spp. protozoans and there is no safe and effective vaccine to reduce its negative consequences. In a previous work by our group, we identified T cell epitopes of Leishmania (Viannia) braziliensis which stimulated patients’ T cells in vitro. In the present work, the peptides were tested as two pools for their ability to rescue memory T cells during natural infection by Leishmania. We analyzed the frequency of central memory (TCM, CD45RA-CD62L+) and effector memory (TEM, CD45RA + CD62L-) cells during active CL and post-treatment. In parallel, we investigated cell proliferation levels and the cytokines produced after stimulation. Interestingly, we observed higher frequencies (%) in CD4+ TEM during CL, and CD8+ TEM and CD8+ TCM during CL and post-treatment. Cell proliferation was increased, and a significant difference in expression was observed on T-bet and RORγT. Besides that, IFN-γ, IL-2, and IL-10 were detected in patient samples. Collectively, this dataset suggests that during CL there is an increase in the frequency of TCM and TEM, especially in the CD8 compartment. These results indicate a potentially immunogenic profile of the peptide pools, which can support the development of anti-Leishmania formulations.

Keywords